Lipoprotein Lipase anticorps (AA 124-475)

N° du produit ABIN7268286

Cet anticorps anti-Lipoprotein Lipase est un anticorps Lapin Polyclonal détectant Lipoprotein Lipase dans WB. Adapté pour Humain.

Aperçu rapide pour Lipoprotein Lipase anticorps (AA 124-475) (ABIN7268286)

Antigène: Lipoprotein Lipase (LPL)

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Lipoprotein Lipase est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-Lipoprotein Lipase anticorps

Épitope: AA 124-475

Fonction: Lipoprotein lipase (LPL) Rabbit pAb

Séquence: SAGYTKLVGQ DVARFINWME EEFNYPLDNV HLLGYSLGAH AAGIAGSLTN KKVNRITGLD PAGPNFEYAE APSRLSPDDA DFVDVLHTFT RGSPGRSIGI QKPVGHVDIY PNGGTFQPGC NIGEAIRVIA ERGLGDVDQL VKCSHERSIH LFIDSLLNEE NPSKAYRCSS KEAFEKGLCL SCRKNRCNNL GYEINKVRAK RSSKMYLKTR SQMPYKVFHY QVKIHFSGTE SETHTNQAFE ISLYGTVAES ENIPFTLPEV STNKTYSFLI YTEVDIGELL MLKLKWKSDS YFSWSDWWSS PGFAIQKIRV KAGETQKKVI FCSREKVSHL QKGKAPAVFV KCHDKSLNKK SG

Réactivité croisée: Humain, Souris, Rat

Attributs du produit: Polyclonal Antibodies

Purification: Affinity purification

Immunogène: Recombinant fusion protein containing a sequence corresponding to amino acids 124-475 of human Lipoprotein lipase (Lipoprotein lipase (LPL)) (NP_000228.1).

Isotype: IgG

Information d'application

Indications d'application: WB,1:500 - 1:2000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur Lipoprotein Lipase

Antigène: Lipoprotein Lipase (LPL)

Autre désignation: LPL

Sujet: LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism.,LPL,HDLCQ11,LIPD,Cancer,Signal Transduction,Endocrine & Metabolism,Lipid Metabolism,Lipases,Endocrine and metabolic diseases,Obesity,Neuroscience,Neurodegenerative Diseases,Stem Cells,Mesenchymal Stem Cells,Cardiovascular,Lipids,LPL

Poids moléculaire: 53kDa

ID gène: 4023

UniProt: P06858

Pathways: Lipid Metabolism